Establishment of anaplastic thyroid carcinoma cell lines useful for analysis of chemosensitivity and carcinogenesis

Journal of Clinical Endocrinology and Metabolism

Volumn 81, Issue 10, 1996, Pages 3547-3552

  Asakawa, Hideki ^a   Kobayashi, Tetsuro ^a   Komoike, Yoshifumi ^a   Yanagawa, Tadashi ^c   Takahashi, Masayoshi ^c   Wakasugi, Eijiro ^a   Maruyama, Hirohide ^b   Tamaki, Yasuhiro ^a   Matsuzawa, Yuji ^a   Monden, Morito ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b Osaka Teishin Hospital   (Japan)

^c SRL INC   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CISPLATIN; DOXORUBICIN; ETOPOSIDE;

ADULT; AGED; ANAPLASTIC CARCINOMA; ARTICLE; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CARCINOGENESIS; CONTROLLED STUDY; DRUG SENSITIVITY; FEMALE; GENE MUTATION; HUMAN; HUMAN CELL; MULTIDRUG RESISTANCE; ONCOGENE; PRIORITY JOURNAL; THYROID CARCINOMA; TUMOR SUPPRESSOR GENE;

AGED; BASE SEQUENCE; CARCINOMA; CISPLATIN; DNA PRIMERS; DOXORUBICIN; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; FEMALE; GENES, P53; GENES, RAS; HUMANS; MIDDLE AGED; MUTATION; OLIGONUCLEOTIDE PROBES; ONCOGENES; RETROSPECTIVE STUDIES; THYROID NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 10244266448     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.81.10.3547     Document Type: Article

References (33)

1. Tennvall J, Lundell G, Hallquist A, et al. 1994 Combined doxorubicin, hyperfractionated radiotherapy, and surgery in anaplastic thyroid carcinoma. Cancer. 74:1345-1354.
2. Kobayashi T, Asakawa H, Umeshita K, et al. 1996 Treatment of 37 patients with anaplastic carcinoma of the thyroid. Head Neck. 18:36-41.
3. Ahujia S, Ernst RD. 1987 Chemotherapy of thyroid carcinoma. J Endocrinol Invest. 10:303-310.
4. Gottlieb JA, Hill Jr CS. 1974 Chemotherapy of thyroid cancer with adriamycin. Experience with 30 patients. N Engl J Med. 290:193-197.
5. Shimaoka K, Schoenfeld DA, Dewys LH. 1985 A randomized trial of doxorubicin versus doxorubicin plus cisplatin in patients with advanced thyroid carcinoma. Cancer. 56:2155-2160.
6. Smith HS, Zoli W, Volpi A, et al. 1990 Preliminary correlations of clinical outcome with in vitro chemosensitivity of second passage human breast cancer cells. Cancer Res. 50:2943-2948.
7. Carmichael J, Mitchell JB, DeGraff WG, et al. 1985 Chemosensitivity testing of human lung cancer cell lines using the MTT assay. Br J Cancer. 57:540-547.
8. Oka K, Kobayashi T, Fujita S, et al. 1993 Establishment of a human anaplastic thyroid cancer cell line secreting granulocyte colony-stimulating factor in response to cytokines. In Vitro Cell Dev Biol 29a:537-542.
9. Pastan I, Gottesman MM. 1991 Multidrug resistance. Annu Rev Med. 42:277-286.
10. Fearon ER, Vogelstein B. 1990 A genetic model for colorectal tumorigenesis. Cell. 61:759-767.
11. Karga H, Lee JK, Vickery AL, Thor A, Gaz RD, Jameson JL. 1991 ras oncogene mutations in benign and malignant thyroid neoplasms. J Clin Endocrinol Metab. 73:832-836.
12. Lemoine NR, Mayall ES, Wyllie FS, et al. 1989 High frequency of ras oncogene activation in all stages of human thyroid tumorigenesis. Oncogene. 4:159-164.
13. Aasland R, Lillehaug JR, Male R, Josendal O, Varhaug JE, Kleppe K. 1988 Expression of oncogenes in thyroid tumours: coexpression of c-erb B2/ neu and c-erb B. Br J Cancer. 57:358-363.
14. Terrier P, Sheng ZM, Schlumberger M, et al. 1988 Structure and expression of c-myc and c-fos proto-oncogenes in thyroid carcinomas. Br J Cancer. 57:43-47.
15. Yamashita S, Ong J, Fagin JA, Melmed S. 1986 Expression of the wyc cellular proto-oncogene in human thyroid tissue. J Clin Endocrinol Metab. 63:1170-1173.
16. Zou M, Shi Y, Farid NR. 1993 p53 mutations in all stages of thyroid carcinomas. J Clin Endocrinol Metab. 77:1054-1058.
17. Nakamura T, Yana I, Kobayashi T, et al. 1992 p53 gene mutations associated with anaplastic transformation of human thyroid carcinoma. Jpn J Cancer Res. 83:1293-1298.
18. Ajani JA, Baker FL, Spitzer G, et al. 1987 Comparison between clinical response and in vitro drug sensitivity of primary human tumors in the adhesive tumor cell culture system. J Clin Oncol. 5:1912-1921.
19. Kitamura M, Furukawa H, Kito T, et al. 1995 Chemosensitivity of gastric cancer using adhesive tumor cell culture system. Oncol Rep. 2:27-31.
20. Fan D, Ajani J, Baker FL, Tomascovic B, Brock WA, Spitzer G. 1987 Comparison of anti-tumor activity of standard and investigational drugs at equivalent granulocyte-macrophage colony forming cell inhibitory concentrations in the adhesive tumor cell culture system: an in vitro method of screening new drags. Eur J Cancer Clin Oncol. 23:1469-1476.
21. Chomczynski P, Sacchi N. 1987 Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 162:156-159.
22. Taparowsky E, Shimizu K, Goldfarb M, Wigler M. 1983 Structure and activation of the human N-ras gene. Cell. 34:581-586.
23. Shimizu K, Goldfarb M, Suard Y, et al. 1983 Three human transforming genes are related to the viral ras oncogenes. Proc Natl Acad Sci USA. 80:2112-2116.
24. Fasano O, Taparowsky E, Fiddes J, Wigler M, Goldfarb M. 1983 Sequence and structure of the coding region of the human H-ras-1 gene from T24 bladder carcinoma cells. J Mol Appl Genet. 2:173-180.
25. Alitalo K, Schwab M, Lin CC, Varmus HE, Bishop M. 1983 Homogeneously staining chromosomal regions contain amplified copies of an abundantly expressed cellular oncogene (c-myc) in malignant neuroendocrine cells from a human colon carcinoma. Proc Natl Acad Sci USA. 80:1707-1711.
26. Yamamoto T, Ikawa S, Akiyama T, et al. 1986 Similarity of protein encoded by the human c-erb-B-2 gene to epidermal growth factor receptor. Nature. 319:230-234.
27. Yamashita T, Watanabe M, Onodera M, et al. 1994 Multi resistance gene and P-glycoprotein expression in anaplastic carcinoma of the thyroid. Cancer Detect Prev. 18:407-413.
28. Miki H, Oshimo K, Inoue H, Morimoto T, Monden Y. 1990 Sex hormone receptors in human thyroid tissues. Cancer. 66:1759-1762.
29. Palyi I, Peter I, Daubner D, Vincze B, Lorincz I. 1993 Establishment, characterization and drug sensitivity of a new anaplastic thyroid carcinoma cell line (BHT-101). Virchows Arch B Cell Pathol. 63:263-269.
30. Tsai CM, Gazdar AF, Venzon DJ, et al. 1989 Lack of in vitro synergy between etoposide and cis-diammine-dichloroplatinum. Cancer Res. 49:2390-2397.
31. Onoda N, Ohmura E, Tsushima T, et al. 1992 Autocrine role of insulin-like growth factor (IGF)-I in a human thyroid cancer cell line. Eur J Cancer, 28A:1904-1909.
32. Enomoto T, Sugawa H, Inoue D, et al. 1990 Establishment of a human undifferentiated thyroid cancer cell line producing several growth factors and cytokines. Cancer. 65:1971-1979.
33. Zeki K, Nakano Y, Inokuchi N, et al. 1993 Autocrine stimulation of interleukin-1 in the growth of human thyroid carcinoma cell line NIM 1. J Clin Endocrinol Metab. 76:127-133.